Response to McKinnell et al's original article "cost-benefit analysis from the hospital perspective of universal active screening followed by contact precautions for methicillin-resistant Staphylococcus aureus carriers"

Infect Control Hosp Epidemiol. 2015 Jul;36(7):856-7. doi: 10.1017/ice.2015.111.

Authors

Mary Teresa O'Riordan¹, Patricia Harrington², Kathleen Mac Lellen¹, Máirín Ryan², Hilary Humphreys³

Affiliations

¹ 1Clinical Effectiveness Unit,Department of Health,Dublin,Ireland.
² 2Health Technology Assessment Directorate,Health Information and Quality Authority,Dublin,Ireland.
³ 4Department of Clinical Microbiology,Royal College of Surgeons in Ireland,Dublin,Ireland.

PMID: 26081998
DOI: 10.1017/ice.2015.111

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Carrier State / diagnosis*
Hospital Costs*
Humans
Infection Control / economics*
Mass Screening / economics*
Methicillin-Resistant Staphylococcus aureus*
Staphylococcal Infections / diagnosis*